Valneva
Valneva UK

Advancing vaccines for better lives

Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Our vision is to contribute to a world in which no one dies or suffers from a vaccine-preventable disease. Valneva UK is providing products to help protect travellers against Japanese encephalitis and cholera. Valneva aims to improve awareness, advice and access to travel health to better protect travellers through working in partnership with healthcare providers.
This website is intended for UK residents.

Our Objectives

Awareness

Increase awareness of travel-related health risks and encourage travellers to seek professional advice before travelling.

Access

Improve accessibility and convenience for travellers seeking advice by supporting the development and expansion of clinics offering comprehensive, high quality and clinically robust travel health services.

Advice

Support healthcare professionals to effectively communicate the benefits of travel health advice to increase the number of travellers protected.

Travelling abroad?

No matter whether you are travelling abroad on holiday, visiting family or friends or going on business, you should consider the potential health-related risks.

"Seek travel health advice at least 6 weeks before travelling."

Risks can include sun stroke, dehydration, altitude sickness and serious travel-related diseases, including but not limited to malaria, hepatitis, rabies, cholera, Japanese encephalitis. If you need vaccinations for your travels, you may need to allow time for more than one dose so plan ahead and seek travel health advice at least 6 weeks before travelling.

Traveltip

To find your nearest convenient pharmacy or specialist travel health clinic for a risk assessment or for a travel health consultation before your trip visit:
bewareofthebugs.com


BB-icon.svg

Disease Awareness

Our Products

We provide a range of prescription only vaccines and medicines as well as consumer products to help protect people while on their travels. The helpful links below provide information on these products for members of the public including their Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL), where applicable.

ProductIndication

IXIARO®Japanese encephalitis vaccine (inactivated, adsorbed)
Prescription only medicine

European Public Assessment ReportFurther information on SMPC and PIL


DUKORAL®Cholera vaccine (inactivated, oral)
Prescription only medicine

European Public Assessment ReportFurther information on SMPC and PIL

Contact

Medical enquiries
T +44 1506 446608
medinfo@valneva.com

Please consult your doctor, pharmacist or a travel health clinic for further information. Product information specifically for healthcare professionals is also available.

Medical Requests COVID-19 Vaccine Candidate
Valneva is developing VLA2001, currently the only whole virus, inactivated, adjuvanted vaccine candidate in clinical trials against COVID-19 in Europe. For medical questions related to Valneva’s COVID-19 vaccine candidate please call +43 1 20620 1444 or send an email to covid19@valneva.com.

Adverse events
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.

2021 - Update your browser...